Prosecution Insights
Last updated: August 16, 2026
Application No. 18/062,372

GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY

Non-Final OA §103
Filed
Dec 06, 2022
Priority
Dec 10, 2021 — provisional 63/288,172
Examiner
SAHAND, SANA
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Novocure GmbH
OA Round
2 (Non-Final)
63%
Grant Probability
Moderate
2-3
OA Rounds
0m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
211 granted / 333 resolved
-6.6% vs TC avg
Strong +24% interview lift
Without
With
+24.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
83 currently pending
Career history
400
Total Applications
across all art units

Statute-Specific Performance

§101
11.4%
-28.6% vs TC avg
§103
51.0%
+11.0% vs TC avg
§102
11.2%
-28.8% vs TC avg
§112
22.5%
-17.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 333 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments in combination with amendments, see Remarks and Claims, filed 05/20/2026, with respect to the rejection(s) of claim(s) under 35 USC 102 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Burnett reference. See details below. Since Burnett reference was not previously provided, this action is being sent out as a second non-final rejection. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 7 is/are rejected under 35 U.S.C. 103 as being unpatentable over CN109224290A to Shi (previously presented) in view of US 20030158585 A1 to Burnett (hereinafter “Burnett”). Regarding claim 7. (Original) Shi discloses a garment for delivering Tumor Treating Fields (TTFields) to a treatment area on or in a body of a subject (abstract, Description; it is noted that “delivering TTFields to a treatment area” is not given any patentable weight, as it does not positively recite the limitation – see MPEP 2111), comprising: a supporting layer having a skin-facing surface configured to be adjacent to the treatment area (Description, “the front fixing belt and a rear fixing belt”); one or more connector disposed on the skin-facing surface of the supporting layer adjacent to a treatment area (Description, “wires”, “electrode tip 3 is connected to the electric pulse generator 4 by a wire”); and an inflatable component comprising one or more bladder (Description “elastic bladder 6”, fig. 1) and supported by the supporting layer at a location associated with the treatment area (Description “the elastic bladder 6 can be integrated in the wearing device 5”), the one or more bladder biased to a neutral position and configured to expand to an inflated position or contract to a deflated position based in part on one or more predetermined pressure (Description; the mesh elastic bladder 6 is filled with water or inflated, and after being expanded, the elastic bladder 6 presses the front fixing belt 1 and the rear fixing belt 2 respectively). Shi fails to explicitly disclose the one or more connector being configured to attach a transducer array to the skin-facing surface of the supporting layer. Burnett, from a similar field of endeavor teaches that it is known to provide array of transducers that is attached by cable (i.e., connector) to the inner insulating layer so as to achieve an orientation where the coils within the array are arranged coaxially within the appliance to parallel the treatment area (para 0050). It would have been obvious to one of ordinary skills in the art prior to the effective filing date of the claimed invention to modify the disclosure of Shi with the teachings of Burnett to provide the predictable result of arranging the coils parallel to the treatment area. Claim(s) 11, 12, 13 and 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Shi as modified by Burnett in view of US Pub No. 20180154140 A1 to Bouton et al. (hereinafter “Bouton” – on IDS). Regarding claim 11. (Original) Shi as modified by Burnett renders obvious the garment of claim 7, configured to selectively provide a fluid at one or more predetermined pressure (Description, “filled with water or inflated”;), and a tube configured to provide fluid communication between the pump and the inflatable component (Description” inflation port or a water filling port”). But fails to explicitly disclose having a pump. Shi discloses an elastic bladder, inflation port, filling port, etc., Bouton, from a similar field of endeavor, teaches providing a pneumatic pump can be used to fill the bladders (Para 0116, 0127). It would have been obvious to one of ordinary skills in the art prior to the effective filing date of the claimed invention to modify the disclosure of Shi as modified by Burnett with the teachings of Bouton, to provide the predictable result of providing the means to inflate the elastic bladder. Regarding claim 12. (Original) Shi as modified by Burnett and Bouton renders obvious the garment of claim 11, wherein the tube comprises one or more hose surrounding one or more fluid pathway, each of the one or more fluid pathway configured to provide fluid communication between the pump and a particular bladder of the one or more bladder (Description” inflation port or a water filling port”; it is noted that the claim only requires one of each (i.e., hose and fluid pathway)). Regarding claim 13. (Original) Shi as modified by Burnett and Bouton renders obvious the garment of claim 11, wherein the one or more bladder is one or more first bladder, the tube is a first tube, and further comprising one or more second bladder, the first tube configured to provide fluid communication between the pump and the one or more first bladder, and further comprising a second tube configured to provide fluid communication between the pump and the one or more second bladder (Bouton, para 0116, 0127). Additionally, the court has held that mere duplication of parts has no patentable significance unless a new and unexpected result is produced. See In re Harza, 274 F.2d 669, 124 USPQ 378 (CCPA 1960). Regarding claim 15. (Original) Shi as modified by Burnett and Bouton renders obvious the garment of claim 11, wherein the pump is part of an electronic apparatus, the electronic apparatus having circuitry to cause the pump to provide the fluid at one or more elevated pressure during a period of time in which a measured impedance is above a predetermined threshold (Bouton, para 0116 “pneumatic pump”; it is understood that the pneumatic pump would include circuitry as claimed). Claim(s) 9, 10 and 14 is/are rejected under 35 U.S.C. 103 as being unpatentable over Shi as modified by Burnett in view of CN111481823A to Hongjie (on IDS). Regarding claim 9. (Original) Shi as modified by Burnett renders obvious the garment of claim 7, wherein the one or more connector is one or more first connector (see rejection of claim 7), but fails to disclose further comprising two or more transducer arrays configured to deliver TTFields to the treatment area, each of the two or more transducer arrays comprising one or more second connector, the one or more second connector configured to attach to the one or more first connector. Hongjie, from a similar field of endeavor, teaches having a plurality of patches associated with a plurality of cloth pieces to allow for providing field energy electrode patch is close to the human body and adapted to the position of the tumor (Description, fig 3). It would have been obvious to one of ordinary skills in the art prior to the effective filing date of the claimed invention to modify the disclosure of Shi as modified by Burnett with the teachings of Hongjie, because doing so would allow for providing additional patches, providing the predictable result of providing field energy electrode adapted to the position of the tumor. Additionally, the court has held that mere duplication of parts has no patentable significance unless a new and unexpected result is produced. See In re Harza, 274 F.2d 669, 124 USPQ 378 (CCPA 1960). Regarding claim 10. (Original) Shi as modified by Burnett renders obvious the garment of claim 7, wherein the inflatable component is a first inflatable component, the one or more bladder is one or more first bladder, the location is a first location (see rejection of claim 7), but fails to disclose the garment further comprising: a second inflatable component comprising one or more second bladder supported by the supporting layer at a second location associated with the treatment area, the one or more second bladder biased to a neutral position and configured to expand to an inflated position or contract to a deflated position based in part on the one or more predetermined pressure. Hongjie, from a similar field of endeavor, teaches having a plurality of patches associated with a plurality of cloth pieces to allow for providing field energy electrode patch is close to the human body and adapted to the position of the tumor (Description, fig 3). It would have been obvious to one of ordinary skills in the art prior to the effective filing date of the claimed invention to modify the disclosure of Shi as modified by Burnett with the teachings of Hongjie, because doing so would allow for providing additional patches, providing the predictable result of providing field energy electrode adapted to the position of the tumor. Shi as modified by Burnett and Hongjie, would render obvious providing additional inflatable components associated with the additional plurality of cloths pieces/patches to provide a biasing force to press the electrodes to the body (Shi, Description). Additionally, the court has held that mere duplication of parts has no patentable significance unless a new and unexpected result is produced. See In re Harza, 274 F.2d 669, 124 USPQ 378 (CCPA 1960). Regarding claim 14. (Original) Shi as modified by Burnett and Hongjie renders obvious the garment of claim 9, wherein each of the one or more bladder comprises a biasing material such that the one or more bladder in the neutral position provides an initial biasing pressure against a particular transducer array of the two or more transducer arrays (Shi, Description, elastic bladder provided on the belt is understood to provide at biasing force). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SANA SAHAND whose telephone number is (571)272-6842. The examiner can normally be reached M-Th 8:30 am -5:30 pm; F 9 am-3 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer S McDonald can be reached at (571) 270- 3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SANA SAHAND/Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Dec 06, 2022
Application Filed
Feb 20, 2026
Non-Final Rejection mailed — §103
May 20, 2026
Response Filed
Jul 28, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702354
BIORHYTHM DETERMINATION METHOD, AND ELECTRONIC DEVICE FOR SUPPORTING SAME
3y 9m to grant Granted Aug 11, 2026
Patent 12661524
MASK WITH VIBRATION AND LIGHT THERAPY
3y 4m to grant Granted Jun 23, 2026
Patent 12653462
AN ASSEMBLY FOR MOUNTING A SENSOR ON SKIN
4y 7m to grant Granted Jun 16, 2026
Patent 12653446
System and Method for measuring progression of Parkinson's Disease using wearables
2y 11m to grant Granted Jun 16, 2026
Patent 12653410
Heart Measurement Using Acoustic Techniques
2y 9m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
63%
Grant Probability
88%
With Interview (+24.5%)
3y 5m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 333 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month